Based on new scientific evidence, the Centers for Disease Control and Prevention (CDC) has updated its US Medical Eligibility Criteria for Contraceptive Use, 2010, issuing revised recommendations for the use of combined hormonal contraceptives by postpartum women.
Based on new scientific evidence, the Centers for Disease Control and Prevention (CDC) has updated its US Medical Eligibility Criteria for Contraceptive Use, 2010, issuing revised recommendations for the use of combined hormonal contraceptives by postpartum women.
Because of the high risk for venous thromboembolism (VTE), women shouldn’t use combined hormonal contraceptives during the first 21 days after delivery, the CDC advises. Women with no risk factors for VTE usually can start the contraceptives between 21 and 42 days postpartum. Women with risk factors for VTE (previous VTE or recent cesarean delivery) generally shouldn’t use this type of contraception. Beyond 42 days after delivery, no restrictions based on postpartum status apply.
CDC recommendations for other contraceptives, including progestin-only contraceptives and intrauterine devices, remain unchanged. These contraceptives can be started immediately after delivery and are safe for postpartum women, including women who are breastfeeding.
The US Medical Eligibility Criteria for Contraceptive Use, 2010 are at http://www.cdc.gov/reproductivehealth/UnintendedPregnancy/USMEC.htm.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More